Key result
HFmrEF is linked to ~3-fold higher mortality vs HFpEF after off-pump CABG.
Why the study?
Data comparing clinical outcomes between patients with HFpEF and HFmrEF undergoing CABG remain limited.
Does HFmrEF increase the risk of adverse clinical outcomes compared to HFpEF in patients undergoing isolated off-pump coronary artery bypass?
Cohort (n=362)
No
Does HFmrEF increase the risk of adverse clinical outcomes compared to HFpEF in patients undergoing isolated off-pump coronary artery bypass?
Answers are grounded in this paper and cite their sources.
Patients with HFmrEF undergoing OPCAB have significantly worse long-term survival and higher rates of heart failure readmission compared to those with HFpEF.
Background/Objectives: Heart failure (HF) phenotype based on left ventricular ejection fraction (LVEF) may be associated with outcomes after coronary revascularization, but data comparing patients with HF with preserved EF (HFpEF) and HF with mildly reduced EF (HFmrEF) undergoing coronary artery bypass grafting (CABG) remain limited. We compared clinical outcomes and longitudinal echocardiographic changes between patients with HFpEF and HFmrEF undergoing isolated off-pump CABG (OPCAB). Methods: We retrospectively analyzed 362 patients with HF who underwent isolated OPCAB between 2012 and 2020, including 273 with HFpEF (LVEF ≥ 50%) and 89 with HFmrEF (LVEF 41–49%). Overall survival was analyzed using Cox regression, and composite cardiovascular adverse events (CCAEs) and their individual components were analyzed using Fine–Gray models. Inverse probability of treatment weighting (IPTW) was used to reduce measured baseline confounding. Longitudinal echocardiographic changes were evaluated using linear mixed-effects models. Results: Patients with HFmrEF had higher baseline NT-proBNP levels and more adverse echocardiographic features than those with HFpEF. In IPTW-weighted analyses, HFmrEF was associated with all-cause mortality (HR, 3.09; 95% CI, 1.39–6.89; p = 0.006), HF readmission (sHR, 5.72; 95% CI, 2.12–15.45; p < 0.001), and CCAEs (sHR, 2.67; 95% CI, 1.37–5.19; p = 0.004). A significant group-by-time interaction was observed for LVEF (p < 0.001), with an early postoperative increase in LVEF in the HFmrEF group. Conclusions: In patients with HF undergoing isolated OPCAB at a single center, HFmrEF was associated with poorer long-term outcomes than HFpEF, although an early postoperative increase in LVEF was observed. These associations may partly reflect differences in baseline HF severity rather than EF category alone.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a cohort in Heart failure undergoing isolated off-pump coronary artery bypass (OPCAB) (n=362). Heart failure with mildly reduced ejection fraction (HFmrEF) vs. Heart failure with preserved ejection fraction (HFpEF) was evaluated on All-cause mortality (HR 3.09, 95% CI 1.39-6.89, p=0.006). In patients with heart failure undergoing isolated off-pump coronary artery bypass, HFmrEF was associated with a significantly higher risk of all-cause mortality compared to HFpEF (HR 3.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: